Trial Profile

Booster Vaccination With Pneumococcal Vaccine GSK1024850A or Prevenar™ Co-administered With Hiberix™ in Children Primed With the Same Vaccines

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary) ; Hib vaccine conjugate
Indications Influenza B virus infections; Otitis media; Pneumococcal infections
Focus Adverse reactions; Registrational
Sponsors GlaxoSmithKline; GSK

Most Recent Events

13 Jan 2012 Actual end date changed from Jan 2010 to May 2009 as reported by ClinicalTrials.gov.
13 Jan 2012 Actual initiation date changed from Jun 2009 to Jun 2008 as reported by ClinicalTrials.gov.
13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00680914).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com